These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 195728)

  • 61. Investigation on lipid separation methods. III. Separation of tri-, di-, 1-mono- and 2-mono-glycerides.
    BORGSTROM B
    Acta Physiol Scand; 1954; 30(2-3):231-9. PubMed ID: 13158097
    [No Abstract]   [Full Text] [Related]  

  • 62. The determination of the total and specific activity of calcified tissue in tracer experiments using 32P. Advantages of the extraction of the inorganic phosphate with the help of a 10% trichloroacetic acid solution.
    CLAASSEN V; WOSTMANN BS
    Biochim Biophys Acta; 1953 Apr; 10(4):632-3. PubMed ID: 13059033
    [No Abstract]   [Full Text] [Related]  

  • 63. The practical benefits of pharmacokinetics in the use of antineoplastic agents.
    Erlichman C; Donehower RC; Chabner BA
    Cancer Chemother Pharmacol; 1980; 4(3):139-45. PubMed ID: 6994913
    [No Abstract]   [Full Text] [Related]  

  • 64. The pharmacokinetics of subcutaneous cytosine arabinoside in patients with acute myelogenous leukaemia.
    Slevin ML; Piall EM; Aherne GW; Johnston A; Sweatman MC; Lister TA
    Br J Clin Pharmacol; 1981 Oct; 12(4):507-10. PubMed ID: 6945865
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A radioimmunoassay for cytosine arabinoside.
    Piall EM; Aherne GW; Marks VM
    Br J Cancer; 1979 Oct; 40(4):548-56. PubMed ID: 574019
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Separation of 5'-mono-, di- and triphosphates of 1-beta-D-arabinofuranosylcytosine and of 1-beta-D-arabinofuranosyluracil by thin-layer and high pressure liquid chromatography.
    Kreis W; Greenspan A; Woodcock T; Gordon C
    J Chromatogr Sci; 1976 Jul; 14(7):331-3. PubMed ID: 956325
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A radioimmunoassay method for 1-beta-D-arabinofuranosyluracil using antibodies directed against 1-beta-D-arabinofuranosylcytosine.
    Okabayashi T; Mihara S; Moffatt JG
    Cancer Res; 1977 Feb; 37(2):625-8. PubMed ID: 12864
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sensitive radioimmunoassay for cytarabine and uracil arabinoside in plasma.
    Sato T; Morozumi M; Kodama K; Kuninaka A; Yoshino H
    Cancer Treat Rep; 1984 Nov; 68(11):1357-66. PubMed ID: 6498853
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A radioimmunoassay for 1-beta-D-arabinofuranosyluracil with reference to cross-reactivity of 1-beta-D-arabinofuranosylcytosine with an antibody.
    Okabayashi T; Mihara S; Repke DB; Moffatt JG
    Cancer Res; 1977 Sep; 37(9):3132-5. PubMed ID: 18280
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Extraction and analytic procedures for cytosine arabinoside and 1-beta-D-arabinofuranosyluracil and their 5'-mono-, di-, and tri-phosphates.
    Kreis W; Gordon C; Gizoni C; Woodcock T
    Cancer Treat Rep; 1977 Jul; 61(4):643-6. PubMed ID: 195728
    [TBL] [Abstract][Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.